🇺🇸 FDA
Pipeline program

rt-PA

MK02-2020-01

Phase 3 small_molecule completed

Quick answer

rt-PA for Acute Ischemic Stroke is a Phase 3 program (small_molecule) at Beijing Tiantan Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Beijing Tiantan Hospital
Indication
Acute Ischemic Stroke
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials